Veteran Biomedical R&D Executive Dr. Vladimir Misik Joins CSOFT Health Sciences as VP of Global Clinical Strategy in Time for DIA 2022

[ad_1]

BOSTON, June 16, 2022 /PRNewswire/ — CSOFT Health and fitness Sciences, chief in clinical translations, is delighted to announce its appointment of Dr. Vladimir Misik as Vice President of World Scientific Strategy, increasing CSOFT’s senior advisory to its scientific trial localization and international regulatory consulting products and services. As a seasoned biomedical R&D govt and founder of numerous biomedical R&D ventures, Dr. Misik joins CSOFT in time for DIA’s to start with in-person Once-a-year Meeting given that the start out of the pandemic, taking position June 19^th to 23^rd in Chicago. In addition to signing up for CSOFT’s on-the-floor staff at Booth 2331, in which he will be obtainable for meetings and discussions, Dr. Misik attends the Annual Meeting as an esteemed member of DIA’s international main committee for clinical analysis.

CSOFT Wellness Sciences is delighted to introduce Dr. Vladimir Misik as Vice President of Worldwide Medical Approach at DIA

“CSOFT is very fired up to welcome Dr. Misik as Vice President next over a year of shut collaboration and planning in partnership with LongTaal, a proprietary scientific demo informatics system launched by Dr. Misik,” stated CSOFT Founder and CEO Ms. Shunee Yee. “We are delighted to be returning to DIA in individual with his deep abilities in scheduling and conducting international scientific trials.”

Primarily based in Vienna, Austria, Dr. Misik brings much more than 30 years’ practical experience in biomedical R&D to his write-up with CSOFT, together with VP of International Shipping and delivery Community and VP of Web site Management at Quintiles/IQVIA, co-founding the VIARES Academy for medical research workforce development, as properly as serving as CEO of SanaClis, a international full-assistance CRO. With a concentration on increasing variety in client recruitment and web-site collection for medical trials, Dr. Misik advises CSOFT in its commitment to offering cross-border conversation solutions for firms participating worldwide markets and regulatory environments, significantly in the EU. Dr. Misik is author of 60+ investigate content articles and e book chapters in peer-reviewed journals. His latest research concentration is globalization of field scientific trials. Leveraging the LongTaal CT analytics system, he introduced the around the world first clinical trial popularity index of international locations. Dr. Misik serves as an editorial board member at Used Clinical Research, Scientific Trials and Regulatory Affairs journal.

Dr. Misik’s earlier collaboration with CSOFT contains his 2021 visual appeal on CSOFT’s Coffee & Conversations webinar, Analyzing Geographical Scientific Trial Tendencies.

DIA’s Global Once-a-year Assembly delivers with each other industry, regulators, lecturers, and sufferers for 4 times of conversations and believed management on the world wide and regional worries facing professionals in the life sciences local community. 2022’s in-individual event, with the theme Innovation As a result of Collaboration, will keep on DIA’s perennial concentration on affected individual centricity and cross-border collaboration as world-wide uncertainty continues to obstacle pharmaceutical exploration and growth. Attendees interested in discovering a lot more about developments in clinical trial localization can go to CSOFT Wellness Sciences at Booth 2331, where Dr. Misik will be readily available all through the lunch hour on Monday and Tuesday, June 21 and 22 (12:00 pm – 1:00 pm). A lot more data about DIA is offered at www.diaglobal.org.

About CSOFT Health and fitness Sciences

CSOFT Overall health Sciences, leaders in clinical translation, supplies conclusion-to-stop health care translations for all phases of the product or service lifecycle, from pre-medical to submit-launch. We also specialize in industry accessibility consulting, health care crafting, and CTD/eCTD submissions with the Fda, EMA, and NMPA.

Our functions are licensed in ISO 17100:2015, ISO 9001:2015, and ISO 13485:2016, ensuring our custom-made remedies satisfy the demanding regulatory specifications of world submissions. Discover much more at lifesciences.csoftintl.com.

Call

Nikki Andrews (U.S./Europe)

+1 (617) 263-8950

nikki.andrews@csoftintl.com

Watch unique written content:https://www.prnewswire.com/information-releases/veteran-biomedical-rd-govt-dr-vladimir-misik-joins-csoft-health-sciences-as-vp-of-international-clinical-technique-in-time-for-dia-2022-301569747.html